Octave at the American Academy of Neurology 2024 Annual Meeting

Monday, April 15 – Thursday, April 18
Denver, Colorado

We had a fantastic time engaging with leading experts in neurology at the 2024 AAN Annual Meeting, where we had the opportunity to present our innovative approach to revolutionizing care in neurodegenerative diseases.

Octave at AAN 2024, wrapped

Oral Presentation by Ferhan Qureshi

Our Senior Vice President of Biomarker R&D, Ferhan Qureshi, presented Octave’s findings on Optic Neuritis (ON), a common manifestation in multiple sclerosis (MS) that can substantially affect patients’ quality of life.

Check out the full presentation here:

Predictive Utility of Serum Protein Biomarkers from the Octave MSDA Panel for Optic Neuritis Events in People with Multiple Sclerosis

E-Poster Presentation

Our team shared how Octave’s 3D brain visualizations in tandem with the topographical model of MS convey disease burden in an intuitive format emphasizes the importance of lesion burden and localization on an individual patient’s disease trajectory.

Check out our collaborative E-Poster:

Novel Visualization of the Topographical Model of Multiple Sclerosis Using 3D Rendering of Quantified MRI

Octave at the American Academy of Neurology 2024 Annual Meeting

Octave at AAN 2024, wrapped

Oral Presentation by Ferhan Qureshi

E-Poster Presentation

To learn more about Octave's innovation, please check out the rest of our publications.